164
Participants
Start Date
October 31, 2013
Primary Completion Date
June 30, 2015
Study Completion Date
June 30, 2015
Fentanyl
Fountain Medical Group, New York
Comprehensive Pain Management, Syosset
APWI, Williamsville
J. Fred Stoner, MD, New Castle
Progressive Pain Solutions, Wind Gap
Cancer Treatment Centers of America, Newnan
Interventional Spine and Pain Management, Atlanta
Florida Cancer Care, Plantation
Physicians Pain Specialists of Alabama, P.C., Mobile
Upper East Side Pain Medicine, P.C., New York
The West Clinic Comprehensive Breast Center, Germantown
Akron General Medical Center, Akron
Advanced Physical Medicine, Saint Clair Shores
Michigan Interventional Pain Center, Brownstown
Michigan Spine & Pain, West Bloomfield
Glenn Saperstein, D.O., LLC, Saginaw
Physiatry Consultants, Bay City
Pain Management Institute, Overland Park
Cancer Treatment Centers of America, Tulsa
PRIDE, Dallas
Red Rocks Center for Rehabilitation, Golden
Pain Centers Nationwide, Peoria
Valley Pain Consultants, Scottsdale
Alexander Ford, MD, Los Angeles
Cancer Care Institute, Los Angeles
Pete J. Ruane, MD, Inc., Los Angeles
Pain Institute of Santa Monica, Santa Monica
Randy Scharlach, MD, Woodland Hills
Coastal Pain Research, Carlsbad
Navajo Road Pain Management Center, El Cajon
Interventional Pain Management, Irvine
California Cancer Associates for Research and Excellence, Inc., Fresno
Columbia Basin Hematology & Oncology, Kennewick
Western Connecticut Health Network, Danbury Hospital, Danbury
Pain Management Associates of CT, PC, Stamford
Jerrold Rosenberg, MD, Providence
Lead Sponsor
Galena Biopharma, Inc.
INDUSTRY